Literature DB >> 24219325

Combined analysis of gamma-H2AX/53BP1 foci and caspase activation in lymphocyte subsets detects recent and more remote radiation exposures.

Simon Horn1, Stephen Barnard, Darren Brady, Kevin M Prise, Kai Rothkamm.   

Abstract

Analysis of gamma-H2AX foci in blood lymphocytes is a promising approach for rapid dose estimation to support patient triage after a radiation accident but has one major drawback: the rapid decline of foci levels post-exposure cause major uncertainties in situations where the exact timing between exposure and blood sampling is unknown. To address this issue, radiation-induced apoptosis (RIA) in lymphocytes was investigated using fluorogenic inhibitors of caspases (FLICA) as an independent biomarker for radiation exposure, which may complement the gamma-H2AX assay. Ex vivo X-irradiated peripheral blood lymphocytes from 17 volunteers showed dose- and time-dependent increases in radiation-induced apoptosis over the first 3 days after exposure, albeit with considerable interindividual variation. Comparison with gamma-H2AX and 53BP1 foci counts suggested an inverse correlation between numbers of residual foci and radiation-induced apoptosis in lymphocytes at 24 h postirradiation (P = 0.007). In T-helper (CD4), T-cytotoxic (CD8) and B-cells (CD19), some significant differences in radiation induced DSBs or apoptosis were observed, however no correlation between foci and apoptosis in lymphocyte subsets was observed at 24 h postirradiation. While gamma-H2AX and 53BP1 foci were rapidly induced and then repaired after exposure, radiation-induced apoptosis did not become apparent until 24 h after exposure. Data from six volunteers with different ex vivo doses and post-exposure times were used to test the capability of the combined assay. Results show that simultaneous analysis of gamma-H2AX and radiation-induced apoptosis may provide a rapid and more accurate triage tool in situations where the delay between exposure and blood sampling is unknown compared to gamma-H2AX alone. This combined approach may improve the accuracy of dose estimations in cases where blood sampling is performed days after the radiation exposure.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24219325     DOI: 10.1667/RR13342.1

Source DB:  PubMed          Journal:  Radiat Res        ISSN: 0033-7587            Impact factor:   2.841


  10 in total

1.  DNA double-strand break repair and induction of apoptosis in ex vivo irradiated blood lymphocytes in relation to late normal tissue reactions following breast radiotherapy.

Authors:  Melvin Lee Kiang Chua; Simon Horn; Navita Somaiah; Sue Davies; Lone Gothard; Roger A'Hern; John Yarnold; Kai Rothkamm
Journal:  Radiat Environ Biophys       Date:  2014-03-13       Impact factor: 1.925

2.  Prostate cancer treated with brachytherapy; an exploratory study of dose-dependent biomarkers and quality of life.

Authors:  Sarah O S Osman; Simon Horn; Darren Brady; Stephen J McMahon; Ahamed B Mohamed Yoosuf; Darren Mitchell; Karen Crowther; Ciara A Lyons; Alan R Hounsell; Kevin M Prise; Conor K McGarry; Suneil Jain; Joe M O'Sullivan
Journal:  Radiat Oncol       Date:  2017-03-14       Impact factor: 3.481

3.  Development of the FAST-DOSE assay system for high-throughput biodosimetry and radiation triage.

Authors:  Qi Wang; Younghyun Lee; Igor Shuryak; Monica Pujol Canadell; Maria Taveras; Jay R Perrier; Bezalel A Bacon; Matthew A Rodrigues; Richard Kowalski; Christopher Capaccio; David J Brenner; Helen C Turner
Journal:  Sci Rep       Date:  2020-07-29       Impact factor: 4.379

4.  DNA damage in blood leucocytes of prostate cancer patients during therapy with 177Lu-PSMA.

Authors:  Sarah Schumann; Harry Scherthan; Constantin Lapa; Sebastian Serfling; Razan Muhtadi; Michael Lassmann; Uta Eberlein
Journal:  Eur J Nucl Med Mol Imaging       Date:  2019-04-27       Impact factor: 9.236

5.  Effect of dose and dose rate on temporal γ-H2AX kinetics in mouse blood and spleen mononuclear cells in vivo following Cesium-137 administration.

Authors:  Helen C Turner; Younghyun Lee; Waylon Weber; Dunstana Melo; Aimee Kowell; Shanaz A Ghandhi; Sally A Amundson; David J Brenner; Igor Shuryak
Journal:  BMC Mol Cell Biol       Date:  2019-05-28

6.  Inverse dose-rate effect of ionising radiation on residual 53BP1 foci in the eye lens.

Authors:  Stephen G R Barnard; Roisin McCarron; Jayne Moquet; Roy Quinlan; Elizabeth Ainsbury
Journal:  Sci Rep       Date:  2019-07-18       Impact factor: 4.379

7.  Quantification of DNA Double Strand Breaks and Oxidation Response in Children and Adults Undergoing Dental CBCT Scan.

Authors:  Niels Belmans; Liese Gilles; Randy Vermeesen; Piroska Virag; Mihaela Hedesiu; Benjamin Salmon; Sarah Baatout; Stéphane Lucas; Ivo Lambrichts; Reinhilde Jacobs; Marjan Moreels
Journal:  Sci Rep       Date:  2020-02-07       Impact factor: 4.379

8.  Early Complications of Radioisotope Therapy with Lutetium-177 and Yttrium-90 in Patients with Neuroendocrine Neoplasms-A Preliminary Study.

Authors:  Barbara Bober; Marek Saracyn; Kornelia Zaręba; Arkadiusz Lubas; Paweł Mazurkiewicz; Ewelina Wilińska; Grzegorz Kamiński
Journal:  J Clin Med       Date:  2022-02-10       Impact factor: 4.241

9.  Repair of α-particle-induced DNA damage in peripheral blood mononuclear cells after internal ex vivo irradiation with 223Ra.

Authors:  Lukas Göring; Sarah Schumann; Harry Scherthan; Uta Eberlein; Jessica Müller; Andreas K Buck; Matthias Port; Michael Lassmann
Journal:  Eur J Nucl Med Mol Imaging       Date:  2022-06-27       Impact factor: 10.057

10.  In vitro Assessment of the DNA Damage Response in Dental Mesenchymal Stromal Cells Following Low Dose X-ray Exposure.

Authors:  Niels Belmans; Liese Gilles; Jonas Welkenhuysen; Randy Vermeesen; Bjorn Baselet; Benjamin Salmon; Sarah Baatout; Reinhilde Jacobs; Stéphane Lucas; Ivo Lambrichts; Marjan Moreels
Journal:  Front Public Health       Date:  2021-02-15
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.